Asuragen, Inc. Becomes The First Certified Service Provider For Illumina Gene Expression Profiling

AUSTIN, Texas & SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) and Asuragen, Inc., an oncology molecular diagnostic company and molecular biology service provider, announced today that Asuragen has successfully completed Illumina Certified Service Provider (CSPro™) certification for gene expression profiling. Asuragen is the first commercial service provider to offer Illumina gene expression profiling services. Illumina, a San Diego, California based company, provides next-generation tools for the large-scale analysis of genetic variation and function.